Skip to content

Sunday, November 15, 2026

Latest:

Incorporating health policy and advocacy in emergency medicine residency
Astrocytes come in specialized types that do different jobs in the brain
VA trial to study effects of GLP-1s for alcohol use disorder among veterans
New treatment reduces heart scarring and abnormal heart rhythms, offering a possibility for future therapies
Testosterone: More than sex, muscle and masculinity

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

brittle bone disease

Targeting TGF-β for treatment of osteogenesis imperfecta

March 22, 2022 brittle bone disease, fresolimumab, osteogenesis imperfecta, Research, TGF-β, treatment

A monoclonal antibody therapy that neutralizes TGF-β produced promising results in a Phase 1 clinical trial.

andersson-dyke-featured-photo

Young author raises brittle bone disease awareness, receives prestigious award

August 8, 2016 Affiliates, Allison Mickey, Andersson Dyke, Awards and Honors, brittle bone disease, Dr. Brendan Lee, Genetics, molecular and human genetics, osteogenesis imperfecta, Osteogenesis Imperfecta Foundation, pediatrics, Texas Children's Hospital

When she was nine years old, Andersson Dyke, a cat lover, began imagining an idea for a story; the journey of an abandoned lion cub

From the Labs: Image of the Month

From the Labs: Brown Fat

Healthy Habits: A DOC-umentary Series

Archives

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951